slotkoers
Korea S.E.
00:00:00 28-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
8.270
KRW
|
-2,71%
|
|
-4,39%
|
+23,43%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
125.732
|
128.479
|
128.907
|
106.418
|
108.894
|
96.901
|
Bedrijfswaarde
1 |
181.452
|
192.361
|
206.112
|
216.672
|
266.249
|
271.874
|
K/w-verhouding
|
-12,7
x
|
163
x
|
93,9
x
|
-19,6
x
|
-3.837
x
|
58,3
x
|
Dividendrendement
|
0,49%
|
0,71%
|
0,73%
|
0,96%
|
-
|
-
|
Marktkapitalisatie/omzet
|
1,33
x
|
1,06
x
|
1,05
x
|
0,79
x
|
0,61
x
|
0,49
x
|
Bedrijfswaarde/omzet
|
1,92
x
|
1,59
x
|
1,68
x
|
1,61
x
|
1,48
x
|
1,38
x
|
Bedrijfswaarde/EBITDA
|
-88,7
x
|
21,8
x
|
19,2
x
|
42,4
x
|
29,6
x
|
23
x
|
Bedrijfswaarde/FCF
|
-93,7
x
|
-19,6
x
|
-15,3
x
|
-6,53
x
|
-7,07
x
|
-9,88
x
|
FCF Yield
|
-1,07%
|
-5,1%
|
-6,53%
|
-15,3%
|
-14,2%
|
-10,1%
|
Price to Book
|
2,24
x
|
2,07
x
|
2,03
x
|
1,59
x
|
0,88
x
|
0,76
x
|
Aantal aandelen (in duizenden)
|
13.428
|
13.428
|
13.767
|
14.036
|
13.961
|
14.463
|
Referentieprijs
2 |
9.364
|
9.568
|
9.364
|
7.582
|
7.800
|
6.700
|
Datum van publicatie
|
14-03-19
|
12-03-20
|
11-03-21
|
14-03-22
|
16-03-23
|
14-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
94.600
|
121.107
|
122.999
|
134.247
|
179.676
|
196.346
|
EBITDA
1 |
-2.046
|
8.812
|
10.738
|
5.112
|
9.006
|
11.828
|
Bedrijfsresultaat (EBIT)
1 |
-5.732
|
4.796
|
6.538
|
399,7
|
4.017
|
6.460
|
Operationele Marge
|
-6,06%
|
3,96%
|
5,32%
|
0,3%
|
2,24%
|
3,29%
|
Resultaat voor belastingen (EBT)
1 |
-8.135
|
1.456
|
1.198
|
-4.761
|
1.058
|
1.424
|
Nettowinst (verlies)
1 |
-8.563
|
786,3
|
1.341
|
-5.347
|
-28,29
|
1.664
|
Nettomarge
|
-9,05%
|
0,65%
|
1,09%
|
-3,98%
|
-0,02%
|
0,85%
|
WPA
2 |
-736,8
|
58,55
|
99,70
|
-386,6
|
-2,033
|
115,0
|
Free Cash Flow
1 |
-1.936
|
-9.807
|
-13.459
|
-33.164
|
-37.685
|
-27.525
|
FCF-marge
|
-2,05%
|
-8,1%
|
-10,94%
|
-24,7%
|
-20,97%
|
-14,02%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
45,45
|
68,18
|
68,18
|
72,73
|
-
|
-
|
Datum van publicatie
|
14-03-19
|
12-03-20
|
11-03-21
|
14-03-22
|
16-03-23
|
14-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
55.719
|
63.882
|
77.205
|
110.254
|
157.355
|
174.973
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-27,23
x
|
7,25
x
|
7,19
x
|
21,57
x
|
17,47
x
|
14,79
x
|
Free Cash Flow
1 |
-1.936
|
-9.807
|
-13.459
|
-33.164
|
-37.685
|
-27.525
|
ROE (netto-inkomsten/eigen vermogen)
|
-16%
|
1,33%
|
2,13%
|
-8,27%
|
-0,03%
|
1,31%
|
ROA (netto-inkomsten/totale activa)
|
-2,53%
|
1,81%
|
2,18%
|
0,12%
|
0,86%
|
1,11%
|
Totale activa
1 |
338.730
|
43.519
|
61.598
|
-4.474.196
|
-3.285
|
149.855
|
Nettoactief per aandeel
2 |
4.177
|
4.621
|
4.616
|
4.776
|
8.830
|
8.838
|
Cashflow per aandeel
2 |
223,0
|
1.241
|
1.162
|
290,0
|
134,0
|
62,70
|
Capex
1 |
3.704
|
13.891
|
17.020
|
32.828
|
48.481
|
24.244
|
Capex/omzet
|
3,92%
|
11,47%
|
13,84%
|
24,45%
|
26,98%
|
12,35%
|
Datum van publicatie
|
14-03-19
|
12-03-20
|
11-03-21
|
14-03-22
|
16-03-23
|
14-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +23,43% | 124 mln. | | +20,76% | 43,77 mld. | | +28,00% | 22,83 mld. | | +20,25% | 15,56 mld. | | +18,82% | 14,34 mld. | | +55,83% | 12,96 mld. | | -0,05% | 6,79 mld. | | -12,70% | 6,41 mld. | | -8,87% | 5,73 mld. | | +14,65% | 5,69 mld. |
Generieke geneesmiddelen
|